| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Genovis AB (publ.) (ST: GENO)
GENO Technical Analysis
2
| As on 9th Jun 2023 GENO STOCK Price closed @ 49.60 and we RECOMMEND Buy for LONG-TERM with Stoploss of 49.33 & Strong Sell for SHORT-TERM with Stoploss of 57.28 we also expect STOCK to react on Following IMPORTANT LEVELS. |
GENOSTOCK Price
| Open | 51.00 | Change | Price | % |
| High | 51.00 | 1 Day | -1.40 | -2.75 |
| Low | 49.15 | 1 Week | -2.40 | -4.62 |
| Close | 49.60 | 1 Month | -6.80 | -12.06 |
| Volume | 58083 | 1 Year | -18.90 | -27.59 |
| 52 Week High 76.10 | 52 Week Low 32.40 | ||||
ST Sweden Most Active Stocks
| QUIA | 0.02 | 0.00% |
| QLIFE | 0.04 | 0.00% |
| SBB-B | 5.38 | 3.07% |
| STRLNG | 0.12 | 33.33% |
| LUNE | 21.97 | 6.65% |
| SAS | 0.36 | 5.88% |
| URBIT | 0.02 | 0.00% |
| IDOGEN | 0.15 | -31.82% |
| STAR-B | 0.89 | -1.11% |
| TELIA | 24.60 | 0.41% |
ST Sweden Top Gainers Stocks
ST Sweden Top Losers Stocks
| GENO Daily Charts |
GENO Intraday Charts |
Whats New @ Bazaartrend |
GENO Free Analysis |
|
|
GENO Important Levels Intraday
| RESISTANCE | 53.16 |
| RESISTANCE | 52.02 |
| RESISTANCE | 51.31 |
| RESISTANCE | 50.61 |
| SUPPORT | 48.59 |
| SUPPORT | 47.89 |
| SUPPORT | 47.18 |
| SUPPORT | 46.04 |
GENO Forecast May 2024
| 4th UP Forecast | 94.88 |
| 3rd UP Forecast | 80.36 |
| 2nd UP Forecast | 71.38 |
| 1st UP Forecast | 62.41 |
| 1st DOWN Forecast | 36.79 |
| 2nd DOWN Forecast | 27.82 |
| 3rd DOWN Forecast | 18.84 |
| 4th DOWN Forecast | 4.32 |
GENO Weekly Forecast
| 4th UP Forecast | 82.74 |
| 3rd UP Forecast | 72.11 |
| 2nd UP Forecast | 65.54 |
| 1st UP Forecast | 58.97 |
| 1st DOWN Forecast | 40.23 |
| 2nd DOWN Forecast | 33.66 |
| 3rd DOWN Forecast | 27.09 |
| 4th DOWN Forecast | 16.46 |
GENO Forecast2024
| 4th UP Forecast | 138.92 |
| 3rd UP Forecast | 110.27 |
| 2nd UP Forecast | 92.57 |
| 1st UP Forecast | 74.86 |
| 1st DOWN Forecast | 24.34 |
| 2nd DOWN Forecast | 6.63 |
| 3rd DOWN Forecast | -11.07 |
| 4th DOWN Forecast | -39.72 |
Genovis AB (publ.) ( ST Sweden Symbol : GENO )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
GENO Business Profile
Genovis AB (publ.) designs, develops, and sells tools for development of drugs for customers in the pharmaceutical and medical device industries. The company offers FabALACTICA, a cysteine protease that digests human IgG1; FabRICATOR, an enzyme that primarily digests the hinge region of IgG; and FabRICATOR Z, an enzyme for the digestion of mouse IgG2a and IgG3, as well as for generating a homogenous pool of F(ab')2 and Fc fragments. It also provides FabULOUS (SpeB), an enzyme for the digestion of IgG in the hinge region; and GingisKHAN, a cysteine protease that digests human IgG1 at a specific site above the hinge. In addition, the company offers GingisREX, a cysteine protease that specifically digests peptide bonds C-terminally to arginine residues; and IgGZERO (EndoS), an endoglycosidase from Streptococcus pyogenes that specifically hydrolyzes N-linked glycans in the Fc-region of native IgG. Further, it provides IgGZERO LE, an endoglycosidase acting on complex type N-glycans from Streptococcus pyogenes; deGlycIT, an IgGZERO (EndoS) enzyme for agarose beads for deglycosylation of Fc-glycans; GlycINATOR an endoglycosidase from Streptococcus pyogenes that hydrolyzes the all glycoforms structure; and GlycINATOR (EndoS2), an endoglycosidase from Streptococcus pyogenes that specifically hydrolyzes glycans at the Fc glycosylation site of IgG. Additionally, the company offers GlyCLICK, a site-specific conjugation technology used for IgG on enzymatic remodeling of the Fc glycans and click chemistry; SialEXO, a sialidase product for the removal and analysis of sialic acids; enzymes for O-glycans; and antibody fragmentation services, as well as operates online store for its products. It serves pharmaceutical and biotech, contract research, and contract manufacturing companies in Sweden, Europe, North America, and Asia. The company has a collaboration with Waters Corporation. Genovis AB (publ.) was founded in 1999 and is based in Lund, Sweden. Address: ScheelevAegen 2, Lund, Sweden, 220 07
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service